Statements (16)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:drug
small molecule |
gptkbp:alternativeName |
PN-235
PTG-200 |
gptkbp:ATCCode |
not assigned
|
gptkbp:clinicalTrialPhase |
Phase 3
|
gptkbp:developedBy |
gptkb:Janssen_Pharmaceuticals
gptkb:Protagonist_Therapeutics |
https://www.w3.org/2000/01/rdf-schema#label |
JNJ-2113
|
gptkbp:indication |
psoriasis
|
gptkbp:mechanismOfAction |
interleukin-23 receptor antagonist
|
gptkbp:routeOfAdministration |
oral
|
gptkbp:status |
investigational
|
gptkbp:target |
IL-23 receptor
|
gptkbp:bfsParent |
gptkb:Protagonist_Therapeutics
|
gptkbp:bfsLayer |
8
|